The estimated Net Worth of William Patrick Burke is at least $1.49 million dollars as of 3 March 2023. Mr Burke owns over 593 units of NovoCure Ltd stock worth over $1,138,731 and over the last 3 years he sold NVCR stock worth over $351,058.
Mr has made over 7 trades of the NovoCure Ltd stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 593 units of NVCR stock worth $45,163 on 3 March 2023.
The largest trade he's ever made was exercising 28,604 units of NovoCure Ltd stock on 3 January 2022 worth over $300,056. On average, Mr trades about 3,032 units every 39 days since 2022. As of 3 March 2023 he still owns at least 66,090 units of NovoCure Ltd stock.
You can see the complete history of Mr Burke stock trades at the bottom of the page.
William Patrick Burke is the Chief HR Officer at NovoCure Ltd.
Mr Burke is 66, he's been the Chief HR Officer of NovoCure Ltd since . There are 2 older and 22 younger executives at NovoCure Ltd. The oldest executive at NovoCure Ltd is Prof. Yoram Palti, 83, who is the Founder & CTO.
William's mailing address filed with the SEC is C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE, PA, 19087.
Over the last 9 years, insiders at NovoCure Ltd have traded over $237,132,855 worth of NovoCure Ltd stock and bought 164,174 units worth $2,198,429 . The most active insiders traders include Asaf Danziger, William Fwfd Ventures Fund ... et Michael J. Ambrogi. On average, NovoCure Ltd executives and independent directors trade stock every 7 days with the average trade being worth of $853,350. The most recent stock trade was executed by Ashley Cordova on 2 August 2024, trading 688 units of NVCR stock currently worth $13,856.
we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.
NovoCure Ltd executives and other stock owners filed with the SEC include: